Who has invested in GluBio Pharmaceutical?

Sanofi are named among the investors backing GluBio Pharmaceutical.

GluBio Pharmaceutical Funding: $30M Raised, Series A (2026)

GluBio Pharmaceutical funding overview

GluBio Pharmaceutical is based in San Diego. GluBio Pharmaceutical has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2026. The round record for GluBio Pharmaceutical runs through 2026; nothing later has been disclosed. Investors on record include Sanofi.

GluBio Pharmaceutical at a glance

Total raised: $30M
Latest round: Series A
Latest round date: February 2026
Headquarters: San Diego
Notable investors: Sanofi

Frequently asked about GluBio Pharmaceutical funding

How much has GluBio Pharmaceutical raised?: GluBio Pharmaceutical has raised $30M in total disclosed funding across the rounds on record.
Who has invested in GluBio Pharmaceutical?: Sanofi are named among the investors backing GluBio Pharmaceutical.
What was the latest GluBio Pharmaceutical funding round?: The most recent disclosed round is a Series A, announced in February 2026.
Where is GluBio Pharmaceutical based?: GluBio Pharmaceutical is based in San Diego.
When did GluBio Pharmaceutical last raise?: The last disclosed GluBio Pharmaceutical round closed in February 2026 at Series A.

Round data for GluBio Pharmaceutical is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.

GluBio Pharmaceutical Funding: $30M Raised, Series A (2026)

GluBio Pharmaceutical funding overview

GluBio Pharmaceutical at a glance

Frequently asked about GluBio Pharmaceutical funding

Companies related to GluBio Pharmaceutical (36)

Browse related funding lists (6)